These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 399187)

  • 21. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
    Vannini P; Ciavarella A; Flammini M; Forlani G; Capelli M; Cocchi V
    Int J Obes; 1982; 6(4):327-34. PubMed ID: 6752059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
    Gragnoli G; Signorini AM; Tanganelli I
    J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin and C-peptide levels in obese patients with polycystic ovaries.
    Pasquali R; Venturoli S; Paradisi R; Capelli M; Parenti M; Melchionda N
    Horm Metab Res; 1982 Jun; 14(6):284-7. PubMed ID: 6749626
    [No Abstract]   [Full Text] [Related]  

  • 24. Decreased insulin removal contributes to hyperinsulinemia in obesity.
    Faber OK; Christensen K; Kehlet H; Madsbad S; Binder C
    J Clin Endocrinol Metab; 1981 Sep; 53(3):618-21. PubMed ID: 7021583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
    Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
    Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreactive dog C-peptide level in the pancreatic vein.
    Kawanishi K; Nishina Y; Ishida T; Machida S; Yamamoto S; Ofuji T; Sakura N; Yanaihara N
    Horm Metab Res; 1980 Dec; 12(12):660-4. PubMed ID: 6162771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic insulin extraction in human pregnancy.
    Kühl C; Hornnes PJ; Faber OK
    Horm Metab Res; 1981 Feb; 13(2):71-2. PubMed ID: 7014408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation and secretion of insulin in hepatic cirrhosis.
    Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
    J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
    Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma C-peptide in uraemic patients.
    Regeur L; Faber OK; Binder C
    Scand J Clin Lab Invest; 1978 Dec; 38(8):771-5. PubMed ID: 741207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous determination of blood insulin and plasma C-peptide levels. Value during assessment of glucose tolerance, especially in obese subjects (author's transl)].
    Pinget M; Demangeat C; Comte F; Brogard JM; Jacques C; Sapin R; Dorner M
    Ann Endocrinol (Paris); 1980; 41(5):399-414. PubMed ID: 7015991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered basal C-peptide/insulin molar ratios in obese patients with fatty liver.
    Inokuchi T; Watanabe K; Kameyama H; Orita M
    Jpn J Med; 1988 Aug; 27(3):272-6. PubMed ID: 3057268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients.
    Osei K; Falko JM; O'Dorisio TM; Adam DR
    Diabetes Care; 1984; 7(5):471-5. PubMed ID: 6389061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent relationship of fasting C-peptide concentration and insulin secretion in non-obese subjects with normal glucose tolerance.
    Ratzmann KP; Strese J; Kohnert KD; Jahr D; Michaelis D
    Exp Clin Endocrinol; 1986 Nov; 88(1):57-63. PubMed ID: 3545858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreative insulin in obesity of adult women.
    Rath R; Slabochova Z; Vondra K
    Int J Obes; 1977; 1(3):279-86. PubMed ID: 617339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced insulin removal and erythrocyte insulin binding in obese children.
    Knip M; Lautala P; Puukka R
    Eur J Pediatr; 1988 Dec; 148(3):233-7. PubMed ID: 3063531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and insulin secretion in fasting high school students.
    Garcia-Webb P; Bonser A; Wearne KL; Gracey M
    Diabetologia; 1980 Sep; 19(3):194-7. PubMed ID: 6997120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoreactive insulin and C-peptide in glucose tolerance disturbances in the relatives of diabetes mellitus patients].
    Mazovetskiĭ AG; Zavadskiĭ PS; Tursunov B; Masenko VP
    Probl Endokrinol (Mosk); 1980; 26(1):8-12. PubMed ID: 7360741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity.
    Savage PJ; Flock EV; Mako ME; Blix PM; Rubenstein AH; Bennett PH
    J Clin Endocrinol Metab; 1979 Apr; 48(4):594-8. PubMed ID: 429504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.